Baldwin Wealth Partners LLC MA Increases Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Baldwin Wealth Partners LLC MA boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 14.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 113,719 shares of the medical device company’s stock after purchasing an additional 13,926 shares during the period. Baldwin Wealth Partners LLC MA owned approximately 0.06% of Cooper Companies worth $10,454,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Ashton Thomas Securities LLC purchased a new stake in Cooper Companies in the 3rd quarter valued at about $25,000. Covestor Ltd increased its position in shares of Cooper Companies by 144.9% during the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after acquiring an additional 200 shares during the last quarter. Brown Brothers Harriman & Co. raised its stake in shares of Cooper Companies by 191.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after acquiring an additional 275 shares during the period. West Financial Advisors LLC acquired a new position in shares of Cooper Companies in the 4th quarter worth approximately $49,000. Finally, Friedenthal Financial acquired a new stake in Cooper Companies in the 3rd quarter valued at approximately $50,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

COO has been the topic of a number of research reports. Wells Fargo & Company upped their price target on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Morgan Stanley lowered their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Finally, Citigroup reduced their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a report on Friday, December 6th. Four investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Stock Up 1.9 %

Shares of NASDAQ COO opened at $99.57 on Monday. The business has a 50-day moving average of $95.95 and a two-hundred day moving average of $99.42. The company has a market capitalization of $19.87 billion, a price-to-earnings ratio of 50.99, a price-to-earnings-growth ratio of 2.41 and a beta of 0.99. The Cooper Companies, Inc. has a 1 year low of $84.76 and a 1 year high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.04. The firm had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm’s revenue was up 9.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.87 earnings per share. On average, analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.